The Maria Sklodowska-Curie National Research Institute of Oncology

Recent papers from The Maria Sklodowska-Curie National Research Institute of Oncology

1. Clinical features of cortisol- and androgen-secreting adrenocortical adenomas: a systematic review of published cases with an illustrative caseFrontiers in Endocrinology · 2026
2. Tumor Treating Fields and Quality of Life Among Patients With Locally Advanced Pancreatic Adenocarcinoma: A Secondary Analysis of a Randomized Clinical TrialJAMA Network Open · 2026
3. Extravasation of antineoplastic agents: a practical drug-by-drug guide for the clinical oncologistNowotwory Journal of Oncology · 2026
4. Long-term exposure to the general external exposome and incidence of ischemic heart disease in Europe: a meta-analysis of 14 cohortsThe Lancet Regional Health - Europe · 2026
5. Mismatch repair deficiency is not associated with AMH/AMHR2 protein expression in endometrial carcinoma: implications for molecular stratificationBMC Cancer · 2026
6. First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trialThe Lancet · 2026
7. Intismeran Autogene plus Pembrolizumab for Resected Stage IIB to IV MelanomaNew England Journal of Medicine · 2026
8. Ultrastructural features associated with the dot-like cytokeratin pattern in Merkel cell carcinoma: a spectrum of intermediate filament organizationFrontiers in Oncology · 2026
9. Baseline Galectin-3 in Patients with Breast Cancer Scheduled for Anthracycline Therapy: Associations with Cardiac Biomarkers, Left Ventricular Function, and HFA-ICOS Risk StratificationInternational Journal of Molecular Sciences · 2026
10. The value of ultrasound-guided core-needle biopsy in the diagnosis of retroperitoneal sarcomasPolish Journal of Surgery · 2026
11. Denosumab in Breast Cancer: Immunobiology, Clinical Evidence and Future PerspectivesAntibodies · 2026
12. Identification of somatic mutations in lymphomas of Bernese Mountain dogsVeterinary oncology. · 2026
13. Hirsutism in Cushing’s syndrome: prospective evidence from the PROMPT study and available literatureFrontiers in Endocrinology · 2026
14. Treatment-related neutropenia as predictor of response to adjuvant palbociclib in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)JNCI Journal of the National Cancer Institute · 2026
15. Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCLAmerican Journal of Hematology · 2026
16. Intracranial Activity of Deruxtecan-Based Antibody–Drug Conjugates in Non-Small Cell Lung Cancer Brain Metastases: A Systematic Review and Meta-Analysis of Prospective Trial CohortsCancers · 2026
17. Quality of life burden in Cushing’s syndrome: baseline results from the PROMPT studyFrontiers in Endocrinology · 2026
18. Indoor Tanning in Europe: Temporal Trends, Sociodemographic Determinants from the Euromelanoma Campaign (2009–2018)Cancers · 2026
19. Simplifying CT / MRI LI ‐ RADS v2018 Maintains Diagnostic Performance: An Individual Participant Data Meta‐AnalysisJournal of Magnetic Resonance Imaging · 2026
20. Guidelines of the Working Group of thePolish Society of Laboratory Diagnostics andCollege of Laboratory Medicine for Diagnosticsof Haemostasis – pre-analytical errors inlaboratory tests in haemostasisDiagnostyka Laboratoryjna · 2026